These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17128916)

  • 1. [Drug-eluting stents can increase the risk of late stent thrombosis].
    Skyttberg N; Linder R; Carlsson J
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
    [No Abstract]   [Full Text] [Related]  

  • 2. [Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents].
    Stenestrand U
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2838-9. PubMed ID: 17128915
    [No Abstract]   [Full Text] [Related]  

  • 3. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
    Ryding AD; Banning AP
    Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815
    [No Abstract]   [Full Text] [Related]  

  • 4. [How does it work? Coronary stent implantation].
    Rampp T; Block M
    MMW Fortschr Med; 2004 Jun; 146(23):64-5. PubMed ID: 15373140
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
    Chhatriwalla AK; Bhatt DL
    Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombosis of pharmacoactive coronary endoprothesis after stopping antiplatelet treatment].
    Saidi Y; Guesmi F; Landolsi M; Trabelsi S; Khemiri K; Ounalli K; Dziri C; Houissa M
    Tunis Med; 2010 Jan; 88(1):63-4. PubMed ID: 20419882
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation.
    Barragan P; Bouvier JL; Roquebert PO; Macaluso G; Commeau P; Comet B; Lafont A; Camoin L; Walter U; Eigenthaler M
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):295-302. PubMed ID: 12822144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Introduction to the topic: drug eluting stents. An underestimated problem in surgery].
    Jähne J; Schirren J
    Chirurg; 2009 Jun; 80(6):497. PubMed ID: 19434381
    [No Abstract]   [Full Text] [Related]  

  • 11. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy.
    Teirstein P; Reilly JP
    J Invasive Cardiol; 2002 Mar; 14(3):109-14. PubMed ID: 11870263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late angiographic stent thrombosis of polymer based paclitaxel eluting stent.
    Lee CH; Lim J; Low A; Tan HC; Lim YT
    Heart; 2006 Apr; 92(4):551-3. PubMed ID: 16537782
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary artery stents: II. Perioperative considerations and management.
    Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stents in interventional cardiology].
    Grinius V; Navickas R; Unikas R
    Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin.
    Olivier AC; Hollman JL
    J Invasive Cardiol; 2006 Jun; 18(6):E185-7. PubMed ID: 16775899
    [No Abstract]   [Full Text] [Related]  

  • 17. Very late thrombosis after implantation of sirolimus eluting stent.
    Karvouni E; Korovesis S; Katritsis DG
    Heart; 2005 Jun; 91(6):e45. PubMed ID: 15894746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous subacute stent thrombosis of two drug-eluting stents in the left anterior descending and the circumflex coronary arteries. Case report and review of the literature.
    Movahed MR; Vu J; Ahsan C
    J Invasive Cardiol; 2006 Jul; 18(7):E198-202. PubMed ID: 16816448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.